Co-Targeting Aurora Kinase With PD-L1 and PI3K Abrogates Immune Checkpoint Mediated Proliferation in Peripheral T-Cell Lymphoma: A Novel Therapeutic Strategy

Oncotarget - United States
doi 10.18632/oncotarget.22222
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Direct Therapeutic Targeting of Immune Checkpoint PD-1 in Pancreatic Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

Therapeutic Options in Peripheral T Cell Lymphoma

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2016English

ARD1-mediated Aurora Kinase a Acetylation Promotes Cell Proliferation and Migration

Oncotarget
Oncology
2017English

Phosphatidylinositol 3-Kinase-Δ (PI3K-δ) Is a Potential Therapeutic Target in Adult T-Cell Leukemia-Lymphoma

Biomarker Research
BiochemistryMolecular MedicineClinical Biochemistry
2018English

The Therapeutic Promise of Disrupting the PD-1/PD-L1 Immune Checkpoint in Cancer: Unleashing the CD8 T Cell Mediated Anti-Tumor Activity Results in Significant, Unprecedented Clinical Efficacy in Various Solid Tumors

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

Breast Care
SurgeryOncology
2016English

PD-L1-specific Helper T-Cells Exhibit Effective Antitumor Responses: New Strategy of Cancer Immunotherapy Targeting PD-L1 in Head and Neck Squamous Cell Carcinoma

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

839 Dual Targeting Autoinflammation and PD-L1/L2 Immune Checkpoint by EGCG Augments Anti-Tumor Effects in Melanoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Crosslink Between Temozolomide and PD-L1 Immune-Checkpoint Inhibition in Glioblastoma Multiforme

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy